Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I

Darci R Smith1, Bradley Hollidge1, Sharon Daye2

  • 1Virology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America.

Insights

A new Zika virus (ZIKV) mouse model using antibody-treated wild-type mice shows high mortality and severe neuropathology, aiding in the study of ZIKV pathogenesis and medical countermeasures.

Area of Science:

  • Virology
  • Immunology
  • Neuropathology

Background:

  • Understanding Zika virus (ZIKV) pathogenesis and developing medical countermeasures requires suitable animal models.
  • Existing mouse models often lack a competent immune system or do not exhibit significant ZIKV-induced disease.

Purpose of the Study:

  • To establish and characterize a novel murine model for ZIKV infection in immunocompetent mice.
  • To evaluate ZIKV pathogenesis and neuropathology in a model that allows for immune responses.

Main Methods:

  • Wild-type C57BL/6 mice were treated with an antibody to block type I interferon (IFN) signaling.
  • Mice were infected with ZIKV via subcutaneous or intraperitoneal routes.
  • Clinical signs, viremia, weight loss, and neuropathological changes were assessed.

Main Results:

  • Antibody-treated mice exhibited high mortality (40% subcutaneous, 100% intraperitoneal).
  • Infected mice displayed significant weight loss, high viremia, and severe central nervous system lesions.
  • Histopathology revealed acute to subacute encephalitis/encephalomyelitis with neuronal death and inflammation.

Conclusions:

  • This IFN I-blocked murine model effectively replicates ZIKV pathogenesis, including severe neuropathology.
  • The model is suitable for evaluating the efficacy of medical countermeasures against ZIKV in immunocompetent hosts.

Related Concept Videos